Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity-Reference-Cited by-同舟云学术

Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity

Published:2005-04-05 Issue:13 Volume:111 Page:1601-1610
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Fisher Patrick W.¹,Salloum Fadi¹,Das Anindita¹,Hyder Haroon¹,Kukreja Rakesh C.¹

Affiliation:

1. From the Department of Internal Medicine, Division of Cardiology, Virginia Commonwealth University Medical Center, Richmond.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Cardiac Failure and Dysrhythmias 6–19 Years After Anthracycline Therapy: A Series of 15 Patients

2. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity

Cited by 299 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating cancer therapy induced cardiotoxicity: From pathophysiology to treatment innovations;Advanced Drug Delivery Reviews;2024-08

2. Inhibidores de la fosfodiesterasa 5 para el tratamiento de la insuficiencia cardiaca: revisión sistemática y metaanálisis de ensayos clínicos aleatorizados;Archivos de Cardiología de México;2024-07-17

3. Protective Effects of Hesperetin on Cardiomyocyte Integrity and Cytoskeletal Stability in a Murine Model of Epirubicin-Induced Cardiotoxicity: A Histopathological Study;Applied Sciences;2024-03-19

4. NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagy;European Journal of Pharmacology;2024-01

5. Multiple pharmacological benefits of sildenafil;AIP Conference Proceedings;2024